| Cas No.: | 41598-07-6 |
| Chemical Name: | Prosta-5,13-dien-1-oicacid, 9,15-dihydroxy-11-oxo-, (5Z,9a,13E,15S)- |
| Synonyms: | Prosta-5,13-dien-1-oicacid, 9,15-dihydroxy-11-oxo-, (5Z,9a,13E,15S)-;Prostaglandin D2;PGD2 (Prostaglandin D2);Prostaglandin D2 Lipid Maps MS Standard;(5Z,9α,13E,15S)-9,15-Dihydroxy-11-oxoprosta-5,13-dien-1-oic-acid;PGD2 |
| SMILES: | OC1CC(=O)C(/C=C/C(O)CCCCC)C1C/C=C/CCCC(O)=O |
| Formula: | C20H32O5 |
| M.Wt: | 352.465086936951 |
| Purity: | >98% |
| Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | Prostaglandin D2 (PGD2) is one of the major PGs actively produced in the brain of various mammals[1]. Prostaglandin D2 is one of the most potent endogenous sleep promoting substances[2]. PGD2 plays a protective role by suppressing inflammation[3]. |
| Target: | Human Endogenous Metabolite |
| In Vivo: | Prostaglandin D2 (PGD2; infused into the lateral ventricle; 5-50 pmol/min; for 6 hours between 20:00 and 2:00) induces sleep-wake profiles in A2AR KO mice[2]. Animal Model: Male WT and A2AR KO mice of the inbred C57BL/6 strain (weighing 23-27 g, 11-13 weeks old)[1] Dosage: 5, 10, 20, or 50 pmol/min Administration: Infused into the lateral ventricle; for 6 hours between 20:00 and 2:00 Result: Induced sleep-wake profiles. |
| References: | [1]. Suzuki F, et al. Transport of prostaglandin D2 into brain. Brain Res. 1986 Oct 22;385(2):321-8. [2]. Zhang BJ, et al. Adenosine A2A receptor deficiency attenuates the somnogenic effect of prostaglandin D2 in mice. Acta Pharmacol Sin. 2017 Apr;38(4):469-476. [3]. Kida T, et al. Prostaglandin D2 Attenuates Bleomycin-Induced Lung Inflammation and Pulmonary Fibrosis. PLoS One. 2016 Dec 19;11(12):e0167729. |

To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
